🧠 Над чим працюють європейські психоделічні стартапи Видання Sifted опитало європейських венчурних інвесторів про найцікавіші стартапи, що займаються психоделіками. Цікаво поглянути, що розробляють ці компанії і як планують заробити на новій хвилі психоделічної терапії: • Psylink — biotech company researching, developing and manufacturing psychoactive compounds • Homecoming — digital companion for therapists to support patients on their journeys with psychedelic-assisted therapy • Ocean Bio — drug discovery company developing a diversified portfolio of clinical assets targeting PTSD and a preventative treatment for migraines • Wavepaths — using psychedelic science, machine learning and music theory, the startup has created a person-centred music solution for practitioners to use during sessions • The Synthesis Institute — aims to deliver safe, legal and medically supervised psychedelic experiences in the Netherlands • Lophora — company develops proprietary new drugs for treatment-resistant depression, and potential further indications including the treatment of anxiety, PTSD and substance abuse • Beckley Psytech — is at the forefront of research into the clinical utility of 5-Meo-DMT (a psychedelic compound found in toad venom) • Lumenate — app provides a pathway to a first “trip” or “psychedelic experience” from the comfort of your couch, without taking any drugs • Earth Resonance — provides a robust access programme to legal magic truffles for microdosing • GH Research — company is focused on the psychedelic compound DMT and is now publicly listed on the NASDAQ • Hive Bio — pioneered the “premium retreat meets clinical therapy” model, with a holistic approach to care delivered on a residential basis